WallStreetZenWallStreetZen

NASDAQ: AMED
AMEDISYS INC Stock

$117.21-3.94 (-3.25%)
Updated May 24, 2022
AMED Price
$117.21
Fair Value Price
$125.45
Market Cap
$3.82B
52 Week Low
$109.53
52 Week High
$276.21
P/E
20x
P/B
3.95x
P/S
2.52x
PEG
2.21x
Dividend Yield
N/A
Revenue
$2.22B
Earnings
$190.87M
Gross Margin
44.2%
Operating Margin
11.96%
Profit Margin
8.6%
Debt to Equity
0.92
Operating Cash Flow
$184M
Beta
0.95
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

AMED Overview

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AMED scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AMED ($117.21) is undervalued by 6.57% relative to our estimate of its Fair Value price of $125.45 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AMED ($117.21) is not significantly undervalued (6.57%) relative to our estimate of its Fair Value price of $125.45 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AMED ($117.21) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AMED due diligence checks available for Premium users.

AMED News

Valuation

AMED fair value

Fair Value of AMED stock based on Discounted Cash Flow (DCF)
Price
$117.21
Fair Value
$125.45
Undervalued by
6.57%
AMED ($117.21) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AMED ($117.21) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AMED ($117.21) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AMED price to earnings (PE)

For valuing profitable companies with steady earnings
Company
20x
Industry
9.85x
Market
21.67x
AMED is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AMED is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

AMED price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.95x
Industry
4.55x
AMED is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AMED price to earnings growth (PEG)

For valuing profitable companies with growth potential
AMED is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

AMED's financial health

Profit margin

Revenue
$545.3M
Net Income
$31.7M
Profit Margin
5.8%
AMED's Earnings (EBIT) of $265.67M... subscribe to Premium to read more.
Interest Coverage Financials
AMED's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.9B
Liabilities
$887.7M
Debt to equity
0.92
AMED's short-term assets ($392.49M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AMED's long-term liabilities ($507.59M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AMED's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
AMED's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$48.6M
Investing
-$16.1M
Financing
-$7.4M
AMED's operating cash flow ($183.51M)... subscribe to Premium to read more.
Debt Coverage Financials

AMED vs Medical Care Facility Stocks

TickerMarket Cap1d %P/EP/B
AMED$3.82B-3.25%20.00x3.95x
AMN$3.94B+0.05%10.37x3.65x
OSH$4.05B-5.08%-8.48x-547.30x
SGRY$3.51B-1.54%-84.89x3.02x
ENSG$4.36B-1.11%21.88x4.07x

AMEDISYS Stock FAQ

What is AMEDISYS's quote symbol?

(NASDAQ: AMED) AMEDISYS trades on the NASDAQ under the ticker symbol AMED. AMEDISYS stock quotes can also be displayed as NASDAQ: AMED.

What is the 52 week high and low for AMEDISYS (NASDAQ: AMED)?

(NASDAQ: AMED) AMEDISYS's 52-week high was $276.21, and its 52-week low was $109.53. It is currently -57.56% from its 52-week high and 7.02% from its 52-week low.

How much is AMEDISYS stock worth today?

(NASDAQ: AMED) AMEDISYS currently has 32,572,820 outstanding shares. With AMEDISYS stock trading at $117.21 per share, the total value of AMEDISYS stock (market capitalization) is $3.82B.

AMEDISYS stock was originally listed at a price of $3.38 in Dec 31, 1997. If you had invested in AMEDISYS stock at $3.38, your return over the last 24 years would have been 3,372.89%, for an annualized return of 15.93% (not including any dividends or dividend reinvestments).

How much is AMEDISYS's stock price per share?

(NASDAQ: AMED) AMEDISYS stock price per share is $117.21 today (as of May 24, 2022).

What is AMEDISYS's Market Cap?

(NASDAQ: AMED) AMEDISYS's market cap is $3.82B, as of May 25, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

AMEDISYS's market cap is calculated by multiplying AMED's current stock price of $117.21 by AMED's total outstanding shares of 32,572,820.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.